99% Savings - Buy Just @1 Rs X
Ryzodeg 100IU/ml Penfill is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Ryzodeg 100IU/ml Penfill safe for pregnant women?
The effects of Ryzodeg on pregnant women are unknown since no research has been done to ascertain it yet.
Is the use of Ryzodeg 100IU/ml Penfill safe during breastfeeding?
In the absence of any scientific study about the side effects of Ryzodeg in breastfeeding women, information on safety of Ryzodeg is unavailable.
What is the effect of Ryzodeg 100IU/ml Penfill on the Kidneys?
Ryzodeg can have moderate side effects on the kidney. If you notice any harmful effects, stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Ryzodeg 100IU/ml Penfill on the Liver?
You may experience side effects on your liver after taking Ryzodeg. If this happens, then discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Ryzodeg 100IU/ml Penfill on the Heart?
Ryzodeg is rarely harmful for the heart.
If you are suffering from any of the following diseases, you should not take Ryzodeg 100IU/ml Penfill unless your doctor advises you to do so -
Is this Ryzodeg 100IU/ml Penfill habit forming or addictive?
Ryzodeg 100IU/ml Penfill is not addictive in nature.
Interaction between Food and Ryzodeg 100IU/ml Penfill
There is no information on the effects of taking Ryzodeg 100IU/ml Penfill with food, because this topic has not been scientifically researched yet.
Interaction between Alcohol and Ryzodeg 100IU/ml Penfill
Drinking alcohol while taking Ryzodeg 100IU/ml Penfill may lead to slight side effects. If you experience any side effects, contact your doctor.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 696
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Tresiba® (insulin degludec)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 265
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; NovoLog (insulin aspart)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Fiasp® (insulin aspart)